Startseite Measurement of 10,11-dihydro-10-hydroxy-carbamazepine in serum and plasma by high-performance liquid chromatography
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Measurement of 10,11-dihydro-10-hydroxy-carbamazepine in serum and plasma by high-performance liquid chromatography

  • Courtney Hunek , Maria Burgyan und Sihe Wang
Veröffentlicht/Copyright: 29. August 2008
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Oxcarbazepine is an antiepileptic drug (AED) used to treat partial seizures as a monotherapy or adjunctive therapy. Oxcarbazepine is metabolized in the liver to its active metabolite, 10,11-dihydro-10-hydroxy-carbamazepine (MHD). Optimal therapeutic effect and minimal toxicity can be achieved through monitoring MHD.

Methods: Serum/plasma was mixed with internal standard (5-ethyl-5-p-tolylbarbituric acid) in methanol and centrifuged for 10 min. The mobile phase consisted of phosphate buffer and acetonitrile (466:168 v/v). The supernatant was analyzed by liquid chromatography (LC) with UV detection at 210 nm.

Results: The linearity ranged from 1.0 to 50.0 μg/mL with analytical recovery of 101.3%–110.8%. The limit of quantification was 1.0 μg/mL. The intra-assay coefficient of variation (CV) was 7.0% and 2.0% for serum samples spiked at 16.3 and 35.8 μg/mL, respectively. The inter-assay CV was 4.3% and 2.3% for serum controls at 7.2 and 23.8 μg/mL, respectively. The method was correlated with a commercial LC-mass spectrometry method using 41 leftover patient samples containing MHD at concentrations of 1.0–36.4 μg/mL, showing a slope of 1.09, an intercept of 1.2 and r=0.9520. No interference was observed from commonly administered AEDs. Commercial controls containing more than 100 therapeutic drugs and endogenous substances were also tested and showed no interference.

Conclusions: This method is simple and effective for monitoring MHD in serum/plasma.

Clin Chem Lab Med 2008;46:1429–33.


Corresponding author: Sihe Wang, Section of Clinical Biochemistry, Department of Clinical Pathology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA Phone: +1-216-445-2634, Fax: +1-216-444-4414,

Received: 2008-5-7
Accepted: 2008-6-2
Published Online: 2008-08-29
Published in Print: 2008-10-01

©2008 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Review
  2. Use of biochemical markers of bone turnover in the management of postmenopausal osteoporosis
  3. Minireview
  4. Is serum procalcitonin able to predict long-term kidney morbidity from urinary tract infections in children?
  5. Genetics and Molecular Diagnostics
  6. Association between the 2756A> G variant in the gene encoding methionine synthase and myocardial infarction in Tunisian patients
  7. Common 894G>T single nucleotide polymorphism in the gene coding for endothelial nitric oxide synthase (eNOS) and risk of congenital heart defects
  8. New sequence variants in BRCA1 and BRCA2 genes detected by high-resolution melting analysis in an elderly healthy female population in Croatia
  9. Enzyme-free signal amplification of analyte in a single closed tube by fluorescent hybridization chain reaction
  10. Five X-chromosome short tandem repeats in a Western Mexican population
  11. General Clinical Chemistry and Laboratory Medicine
  12. Prolyl-hydroxyproline dipeptide in non-hydrolyzed morning urine and its value in postmenopausal osteoporosis
  13. Methionine metabolism in an animal model of sepsis
  14. Hypochlorous acid is a potent inactivator of human plasminogen at concentrations secreted by activated granulocytes
  15. Association of serum γ-glutamyltransferase with C-reactive protein levels and white blood cell count in Korean adults
  16. Immunoradiometric determination of thyroglobulin in serum samples by time calibration transfer
  17. Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients
  18. Measurement of 10,11-dihydro-10-hydroxy-carbamazepine in serum and plasma by high-performance liquid chromatography
  19. The relationship between usual coffee consumption and serum C-reactive protein level in a Japanese female population
  20. Reference Values and Biological Variations
  21. Analytical quality goals for parathyroid hormone based on biological variation
  22. Preanalytical effects of pneumatic tube transport on routine haematology, coagulation parameters, platelet function and global coagulation
  23. Validation and Outcome Studies
  24. Automated immunoassay methods for ferritin: recovery studies to assess traceability to an international standard
  25. An expert system for the classification of serum protein electrophoresis patterns
  26. Impact of a satellite laboratory on turnaround times for the emergency department
  27. Effect of ampicillin-sulbactam on clinical capillary zone electrophoresis of serum proteins
  28. Guidelines and Recommendations
  29. Protein standardization V: value transfer. A practical protocol for the assignment of serum protein values from a Reference Material to a Target Material
  30. Letter to the Editor
  31. Biological variability evaluation and comparison of three different methods for C-peptide measurement
  32. Abstracts
  33. 10.1515/CCLM.2008.361
Heruntergeladen am 18.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2008.276/html
Button zum nach oben scrollen